PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

How the surfaces of silicone breast implants affect the immune system

Implant surface topography can influence the development of scarring, inflammation, and other complications, researchers find

How the surfaces of silicone breast implants affect the immune system
2021-06-21
(Press-News.org) CAMBRIDGE, MA -- Every year, about 400,000 people receive silicone breast implants in the United States. According to data from the U.S. Food and Drug Administration, a majority of those implants needs to be replaced within 10 years due to the buildup of scar tissue and other complications.

A team led by MIT researchers has now systematically analyzed how the varying surface architecture found in these implants influences the development of adverse effects, which in rare cases can include an unusual type of lymphoma.

"The surface topography of an implant can drastically affect how the immune response perceives it, and this has important ramifications for the [implants'] design," says Omid Veiseh, a former MIT postdoc. "We hope this paper provides a foundation for plastic surgeons to evaluate and better understand how implant choice can affect the patient experience."

The findings could also help scientists to design more biocompatible implants in the future, the researchers say.

"We are pleased that we were able to bring new materials science approaches to better understand issues of biocompatibility in the area of breast implants. We also hope the studies that we conducted will be broadly useful in understanding how to design safer and more effective implants of any type," says Robert Langer, the David H. Koch Institute Professor at MIT and the senior author of the study.

Veiseh, who is now an assistant professor at Rice University, and Joshua Doloff, a former MIT postdoc who is now an assistant professor at Johns Hopkins University, are the lead authors of the paper, which appears today in Nature Biomedical Engineering. The research team also includes scientists from Rice University, Johns Hopkins, Establishment Labs, and MD Anderson Cancer Center, among other institutions.

Surface analysis

Silicone breast implants have been in use since the 1960s, and the earliest versions had smooth surfaces. However, with these implants, patients often experienced a complication called capsular contracture, in which scar tissue forms around the implant and squeezes it, creating pain or discomfort as well as visible deformation of the implant. These implants could also flip after implantation, requiring them to be surgically adjusted or removed.

In the late 1980s, some companies began making implants with rougher surfaces, with the hopes of reducing capsular contracture rates and making them "stick" better to the tissue and stay in place. They did this by creating a surface with peaks extending up to hundreds of microns above the surface.

However, in 2019, the FDA requested a breast implant manufacturer to recall all highly textured breast implants (about 80 microns) marketed in the United States due to risk of breast implant-associated anaplastic large cell lymphoma, a cancer of the immune system.

A new generation of breast implants that dates back a decade, having a unique and patented surface architecture that includes not only a slight degree of surface roughness, with an average of about 4 microns, but also other specific surface characteristics including skewness and the number, distribution, and size of contact points optimized to cellular dimensions, was designed to prevent those complications.

In 2015, Doloff, Veiseh, and researchers from Establishment Labs teamed up to explore how this unique surface, as well as others commonly used, interact with the surrounding tissue and the immune system. They began by testing five commercially available implants with different topographies, including degree of roughness. These included the highly textured one that had been previously recalled, one that is completely smooth, and three that are somewhere in between. Two of these implants had the aforementioned novel surface architecture, one with a 4-micron roughness and one with a 15-micron roughness, manufactured by Establishment Labs.

In a study of rabbits, the researchers found that tissue exposed to the roughest implant surfaces showed signs of increased activity from macrophages -- immune cells that normally clear out foreign cells and debris.

All of the implants stimulated immune cells called T cells, but in different ways. Implants with rougher surfaces stimulated more pro-inflammatory T cell responses, while implants with the unique surface topography, including 4-micron average roughness, stimulated T cells that appear to inhibit tissue inflammation.

The researchers' findings suggest that rougher implants rub against the surrounding tissue and cause more irritation. This may offer an explanation for why the rougher implants can lead to lymphoma: The hypothesis is that some of the texture sloughs off and gets trapped in nearby tissue, where it provokes chronic inflammation that can eventually lead to cancer.

The researchers also tested miniaturized versions of these implants in mice. They manufactured these implants using the same techniques used to manufacture the human-sized versions, and showed that more highly textured implants provoked more macrophage activity, more scar tissue formation, and higher levels of inflammatory T cells. The researchers also performed single-cell RNA sequencing of immune cells from these tissues to confirm that the cells were expressing pro-inflammatory genes.

"While completely smooth surface implants also had higher levels of macrophage response and fibrosis, it was very clear in mice that individual cells were more stressed and were expressing more of a pro-inflammatory phenotype in response to the highest surface roughness," Doloff says.

On the other hand, implants with the unique surface architecture, including an optimized degree or "sweet spot" of surface roughness, at about 4 microns on average, and other specific characteristics, appeared to significantly reduce the amount of scarring and inflammation, compared to either the implants with higher roughness or a completely smooth surface.

"We believe that this is due to such surface architecture existing on the scale of individual cells of the body, allowing the cells to perceive them in a different way," Doloff says.

Toward safer implants

After performing their animal studies, the researchers analyzed samples from a large bank of cancer tissue samples at MD Anderson to study how human patients respond to different types of silicone breast implants.

In those samples, the researchers found evidence for the same types of immune responses that they had seen in the animal studies. Among their findings, they observed that tissue samples that had been host to highly textured implants for many years showed signs of a chronic, long-term immune response. They also found that scar tissue was thicker in patients who had more highly textured implants.

"Doing across-the-board comparisons in mice, rabbits, and then in human [tissue samples] really provides a much more robust and substantial body of evidence about how these compare to one another," Veiseh says.

The authors hope that their datasets will help other researchers optimize the design of silicone breast implants and other types of medical silicone implants for better safety.

"The importance of science-based design that can provide patients with safer breast implants was confirmed in this study," says Roberto de Mezerville, an author of the paper and head of R&D at Establishment Labs. "By demonstrating for the first time that an optimal surface architecture allows for the least possible inflammation and foreign-body response, this work is a significant contribution to the entire medical device industry."

INFORMATION:

Other authors of paper include Marcos Sforza, Tracy Ann Perry, Jennifer Haupt, Morgan Jamiel, Courtney Chambers, Amanda Nash, Samira Aghlara-Fotovat, Jessica Stelzel, Stuart Bauer, Sarah Neshat, John Hancock, Natalia Araujo Romero, Yessica Elizondo Hidalgo, Isaac Mora Leiva, Alexandre Mendonca Munhoz, Ardeshir Bayat, Brian Kinney, H. Courtney Hodges, Roberto Miranda, and Mark Clemens.

The research was funded by Establishment Labs.


[Attachments] See images for this press release:
How the surfaces of silicone breast implants affect the immune system

ELSE PRESS RELEASES FROM THIS DATE:

Scientists develop energy saving technique paving way for a carbon neutral society

Scientists develop energy saving technique paving way for a carbon neutral society
2021-06-21
Researchers at the University of Bristol have discovered a method which will allow for faster communication systems and better energy saving electronics. The breakthrough was made by establishing how to remotely measure the electric field inside a semiconductor device for the first time. A semiconductor is a material, such as Silicon, which can be used in electronic devices to control electric current. Now, in this new study, published today in Nature Electronics, scientists outline how to precisely quantify this electric field, meaning next generation power and radio frequency electronic devices can be developed which have the potential to be faster, and more reliable, as well as more energy ...

This molecule is made from sugar, shaped like a doughnut, and formed using light

This molecule is made from sugar, shaped like a doughnut, and formed using light
2021-06-21
A process using a light-sensitive chemical can drastically reduce cost and energy consumption to produce gamma-cyclodextrin, a compound that is widely used in manufacturing, according to a Dartmouth study. The research, published in Chem, demonstrates how a hydrazone template can replace energy-intensive distillation to produce and isolate gamma-cyclodextrin--a water-soluble chemical that attracts other molecules and is used to enhance food, pharmaceuticals, and a wide range of consumer products. "These compounds are biodegradable, biocompatible, benign and commonly used," said Ivan Aprahamian, a professor of chemistry at Dartmouth. "We are making ...

Protein linked to heart health, disease a potential therapeutic target for dementia

Protein linked to heart health, disease a potential therapeutic target for dementia
2021-06-21
By the time people with Alzheimer's disease start exhibiting difficulty remembering and thinking, the disease has been developing in their brains for two decades or more, and their brain tissue already has sustained damage. As the disease progresses, the damage accumulates, and their symptoms worsen. Researchers at Washington University School of Medicine in St. Louis have found that high levels of a normal protein associated with reduced heart disease also protect against Alzheimer's-like brain damage - at least in mice. The findings, published June 21 in Neuron, suggest that raising levels ...

Investigational Alzheimer's drug improves biomarkers of the disease

Investigational Alzheimers drug improves biomarkers of the disease
2021-06-21
An investigational Alzheimer's drug reduced molecular markers of disease and curbed neurodegeneration in the brain, without demonstrating evidence of cognitive benefit, in a phase 2/3 clinical trial led by researchers at Washington University School of Medicine in St. Louis through its Dominantly Inherited Alzheimer Network-Trials Unit (DIAN-TU). These results led the trial leaders to offer the drug, known as gantenerumab, to participants as part of an exploratory open-label extension. The researchers continue to monitor changes in measures of Alzheimer's disease in those participants who are receiving the drug. The DIAN-TU study (ClinicalTrials.gov Identifier: NCT01760005), published June 21 in Nature Medicine, evaluated the effects of two investigational drugs - ...

Projections of US high-tide flooding show rapid increases and extreme months

Projections of US high-tide flooding show rapid increases and extreme months
2021-06-21
In the mid-2030s, multiple United States coastal regions may see rapid increases in the number of high-tide flooding (HTF) days, according to a study led by the University of Hawai'i at Mānoa and published today in Nature Climate Change. The combined effects of sea-level rise (SLR) and natural fluctuations in tidal range are anticipated to cause tipping points in the frequency of HTF. Coastal locations around the U.S., particularly along the Atlantic coast, are experiencing recurrent flooding at high tide. The impact of HTF accumulates over numerous seemingly minor occurrences, which can exceed the impact of rare extremes over time. These impacts are subtle--for example, the loss of revenue due to recurrent road and business closures--compared with the physical damage of property ...

Targeted therapy could be first line treatment for childhood cancer

2021-06-21
Scientists studying a common childhood cancer have made a major breakthrough which could lead to a cure for some youngsters who would not have survived the condition. An international study, involving Newcastle University, UK, has for the first time found a genetic marker in tumours from patients with high-risk neuroblastoma. Research, published in the Journal of Clinical Oncology, has identified that alterations in the neuroblastoma's ALK (anaplastic lymphoma kinase) gene are associated with a significantly poorer prognosis for children with high-risk disease. Experts ...

Fertility drugs do not increase breast cancer risk, study finds

2021-06-21
Drugs routinely used during fertility treatments to release eggs do not increase the risk of developing breast cancer, new research has shown. Researchers from King's College London, in partnership with King's Fertility, analysed studies involving 1.8 million women undergoing fertility treatments. These women were followed up in studies for an average period of 27 years and had no increase in the risk of developing breast cancer. The research, published today in Fertility and Sterility journal, is the largest study to date assessing whether commonly used fertility drugs are for a cancer risk for women. Fertility treatments can range from using medications to boost the release of an egg in a women's natural cycle to more complex ...

Significant inequalities observed in popular Liverpool 'mass testing' pilot

2021-06-21
A study by the University of Liverpool has shown that while asymptomatic COVID-19 testing in Liverpool was popular, significant inequalities were evident between those who got tested and those who didn't. Published in the journal The Lancet Regional Health - Europe, the study found that 43% of residents aged over 5 years (n = 214 525) took up the offer of free testing for people without symptoms of COVID-19 between 6th November 2020 and 31st January 2021. A total of 1.3% of tests were positive, meaning that 5192 individuals who did not know they had the virus were notified ...

Adjuvant-free avian influenza vaccines in the works

Adjuvant-free avian influenza vaccines in the works
2021-06-21
The avian influenza, an acute viral infectious disease that occurs in poultry such as chickens, ducks, and migratory birds, has been reported to be transmittable to humans. It is difficult to control because it spreads among migratory birds that travel to China, Europe, and elsewhere. Once it is transmitted, it spreads rapidly. Disposing infected livestock is not only costly, but also a cause of serious environmental pollution. This is why vaccines against infectious diseases are imperative. To this, a research team in Korea has recently developed a plant-based, adjuvant-free, recombinant protein vaccine that exhibits a strong immune response. Professor ...

A tapeworm drug against SARS-CoV-2?

A tapeworm drug against SARS-CoV-2?
2021-06-21
Researchers from the German Center for Infection Research (DZIF) at Charité - Universitätsmedizin Berlin and the University of Bonn have examined the way in which SARS-CoV-2 reprograms the metabolism of the host cell in order to gain an overall advantage. According to their report in Nature Communications*, the researchers were able to identify four substances which inhibit SARS-CoV-2 replication in the host cell: spermine and spermidine, substances naturally found in the body; MK-2206, an experimental cancer drug; and niclosamide, a tapeworm drug. Charité is currently conducting a trial to determine whether niclosamide is also effective against COVID-19 in humans. Viral replication depends on host cell machinery and ...

LAST 30 PRESS RELEASES:

New research boosts future whooping cough vaccines

Mechanistic understanding could enable better fast-charging batteries

No bones about it: new details about skeletal cell aging revealed

UNM scientists discover how nanoparticles of toxic metal used in MRI scans infiltrate human tissue

UMaine research examines best methods for growing Atlantic sea scallops

Medical cannabis could speed recovery, especially at community recovery homes

Study assesses U.S. image amid weakening of democracy

Two scientific researchers to receive 2025 Ralph L. Sacco Scholarships for Brain Health

Researchers improve chemical reaction that underpins products from foods to fuels

Texas Tech to develop semiconductor power devices through $6 million grant

Novel genomic screening tool enables precision reverse-engineering of genetic programming in cells

Hot Schrödinger cat states created

How cells repair their power plants

Oxygen is running low in inland waters—and humans are to blame

ACP’s Best Practice Advice addresses use of cannabis, cannabinoids for chronic noncancer pain

Beyond photorespiration: A systematic approach to unlocking enhanced plant productivity

How a small number of mutations can fuel outbreaks of western equine encephalitis virus

Exposure to wildfire smoke linked with worsening mental health conditions

Research uncovers hidden spread of one of the most common hospital-associated infections

Many older adults send their doctors portal messages, but who pays?

Fine particulate matter from 2020 California wildfires and mental health–related emergency department visits

Gender inequity in institutional leadership roles in US academic medical centers

Pancreatic cells ‘remember’ epigenetic precancerous marks without genetic sequence mutations

Rare combination of ovarian tumors found in one patient

AI-driven clinical recommendations may aid physician decision making to improve quality of care

Artificial intelligence has potential to aid physician decisions during virtual urgent care

ACP and Annals of Internal Medicine present breaking scientific news at ACP’s Internal Medicine Meeting 2025

New study reveals polymers with flawed fillers boost heat transfer in plastics

Signs identified that precede sudden arrhythmic death syndrome in young people

Discovery of bacteria's defence against viruses becomes a piece of the puzzle against resistance

[Press-News.org] How the surfaces of silicone breast implants affect the immune system
Implant surface topography can influence the development of scarring, inflammation, and other complications, researchers find